Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending March 2012. The report details a specific share repurchase transaction executed on March 2, 2012, in accordance with shareholder authority granted at the Annual General Meeting on May 5, 2011.
Key Financial Metrics
The filing does not provide comprehensive financial statements such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to the share buyback activity:
- Shares Purchased: 650,000 Ordinary shares of 25 pence each.
- Price Range: Highest price paid was 1,409.0 pence per share; lowest price paid was 1,390.0 pence per share.
- Treasury Holdings: Post-transaction, the Company holds 508,027,927 shares in Treasury (9.14% of total issued share capital).
- Total Voting Rights: Including unsettled purchases, Treasury holdings represent 10.10% of total voting rights.
- Shares in Issue: 5,048,749,945 shares (excluding Treasury shares).
Material Changes
The filing does not provide comparative financial data or material changes regarding operational performance versus prior periods. The primary change reported is the reduction of outstanding shares through the repurchase of 650,000 shares and the subsequent increase in Treasury stock holdings.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or discussion of risks and contingencies. It is a compliance disclosure confirming conformity with the Financial Services Authority's Disclosure and Transparency Rules and explicitly states it does not constitute an offer to purchase or subscribe for securities.
Investor Verification Checklist
- Verify the total number of shares held in Treasury (508,027,927) against the latest quarterly or annual reports.
- Confirm the total issued share capital to validate the 9.14% Treasury ownership calculation.
- Check subsequent filings for the settlement status of the 1,770,000 shares mentioned as "purchased but not yet settled" to reconcile the 10.10% voting rights figure.
- Review the Annual General Meeting minutes from May 5, 2011, to confirm the scope of the share repurchase authority utilized.